Gain Therapeutics Inc. (GANX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Gain Therapeutics Inc.

    NASDAQ: GANX · Real-Time Price · USD
    1.92
    0.06 (3.23%)
    At close: Oct 03, 2025, 3:59 PM
    1.95
    1.56%
    After-hours: Oct 03, 2025, 07:58 PM EDT

    Gain Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 10.39M 11.79M 7.31M 36.88M
    Short-Term Investments
    		 n/a 5M 12.83M n/a
    Long-Term Investments
    		 31.7K n/a 1.94M 31.28K
    Other Long-Term Assets
    		 32.11K 51.91K 48.32K 53.39K
    Receivables
    		 765.76K 242.58K 103.88K 195.45K
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 369.89K n/a 640.31K n/a
    Total Current Assets
    		 11.6M 17.78M 21.09M 37.72M
    Property-Plant & Equipment
    		 323.33K 585.18K 804.31K 1.01M
    Goodwill & Intangibles
    		 134.27K 193.38K 213.97K 202.61K
    Total Long-Term Assets
    		 521.41K 830.46K 3.01M 1.26M
    Total Assets
    		 12.12M 18.61M 24.1M 38.99M
    Account Payables
    		 946.26K 1.32M 1.63M 560.48K
    Deferred Revenue
    		 252.21K 1.12M 55.18K 266.5K
    Short-Term Debt
    		 110.18K 118.8K 108.14K 103.83K
    Other Current Liabilities
    		 18.49K 1.38M 364.11K 380.00
    Total Current Liabilities
    		 3.91M 4.95M 4.13M 2.55M
    Long-Term Debt
    		 328.33K 449.05K 495.26K 590.47K
    Other Long-Term Liabilities
    		 443.62K 307.45K 157.58K 329.46K
    Total Long-Term Liabilities
    		 872.99K 1.08M 1.09M 1.61M
    Total Liabilities
    		 4.78M 6.03M 5.22M 4.17M
    Total Debt
    		 653.01K 1.03M 1.27M 1.61M
    Book Value
    		 7.34M 12.58M 18.88M 34.82M
    Book Value Per Share
    		 0.32 0.97 1.59 3.43
    Common Stock
    		 2.71K 1.62K 1.19K 1.19K
    Retained Earnings
    		 -81.19M -60.78M -38.52M -20.93M
    Comprehensive Income
    		 -247.55K 247.24K 35.63K -90.64K
    Shareholders Equity
    		 7.34M 12.58M 18.88M 34.82M
    Total Investments
    		 31.7K 5M 14.77M 31.28K

    Add to Watchlist